Petros Pharmaceuticals, Inc. (PTPI) Free cash flow 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.6MFY2024 · since FY2020: -$15.3M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | — |
| FY2020 | -$15.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →